Pluri Inc. Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value
Pluri Inc. (PLUR) had Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value of $36.00 thousand as of 2013-12-31, per its 10-Q filed 2014-02-05.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments › Foreign Currency Derivatives
us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue · last filed 2014-02-05
- 2013-12-31: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value $36.00K.
- 2013-06-30: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value $93.00K.
| Period end | Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value |
|---|---|
| 2013-12-31 | $36.00K 10-Q · filed 2014-02-05 |
| 2013-06-30 | $93.00K 10-Q · filed 2014-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |